Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma

Henrik Schmidt, Julia S Johansen, Pia Sjoegren, Ib J Christensen, Boe S Sorensen, Kirsten Fode, Jorn Larsen, Hans von der Maase

57 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences